CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Indivior Inc. v. Teva Pharmaceuticals USA, Inc.

1:16-cv-00178

Overview

Case Number 1:16-cv-00178
Filing Date 2016-03-21
Status Terminated
Termination Date 2019-09-05
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Indivior Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Counter Defendant

MonoSol Rx, LLC Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Indivior UK Limited NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 20 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (20): πŸ‡¨πŸ‡¦ Canada CN πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan KR πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8475832
Sublingual and buccal film compositions
Filed: 2009-08-07
Issued: 2013-07-02
Active (3.3 yrs remaining) +231d PTA
Expires: 2030-03-26
US8017150
Polyethylene oxide-based films and drug delivery systems made therefrom
Filed: 2008-04-22
Issued: 2011-09-13
Expired (Term Ended)
Expires: 2023-10-10
US8603514
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Filed: 2007-07-10
Issued: 2013-12-10
Expired (Term Ended)
Expires: 2024-04-03
US8900497
Process for making a film having a substantially uniform distribution of components
Filed: 2013-08-23
Issued: 2014-12-02
Active (6.8 yrs remaining)
Expires: 2033-08-23
US8906277
Process for manufacturing a resulting pharmaceutical film
Filed: 2013-08-23
Issued: 2014-12-09
Active (6.8 yrs remaining)
Expires: 2033-08-23

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+231 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

1

Granted

1

Denied

0

Pending / Review

0

Motions by Category

Motion to Dismiss 1

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORDER of USCA. Decision of USCA: The motion to dismiss is granted (see Order for further details). (nms) (Entered: 06/08/2018)
Entry #32 • 2018-06-08 Document →

Docket Entries

(80 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1899234.) - filed by Indivior Inc., Indivior UK Limited, MonoSol Rx, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D part 1, # 5 Exhibit D part 2, # 6 Exhibit E part 1, # 7 Exhibit E part 2, # 8 Civil Cover Sheet)(nmb) (Entered: 03/22/2016)

Entry #1 • 2016-03-21
1
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1899234.) - filed by Indivior Inc., Indivior UK Limited, MonoSol Rx, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D part 1, # 5 Exhibit D part 2, # 6 Exhibit E part 1, # 7 Exhibit E part 2, # 8 Civil Cover Sheet)(nmb) (Entered: 03/22/2016)

Entry #1 • 2016-03-21
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1899234.) - filed by Indivior Inc., Indivior UK Limited, MonoSol Rx, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D part 1, # 5 Exhibit D part 2, # 6 Exhibit E part 1, # 7 Exhibit E part 2, # 8 Civil Cover Sheet)(nmb) (Entered: 03/22/2016)

Entry #1 • 2016-03-21
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1899234.) - filed by Indivior Inc., Indivior UK Limited, MonoSol Rx, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D part 1, # 5 Exhibit D part 2, # 6 Exhibit E part 1, # 7 Exhibit E part 2, # 8 Civil Cover Sheet)(nmb) (Entered: 03/22/2016)

Entry #1 • 2016-03-21
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1899234.) - filed by Indivior Inc., Indivior UK Limited, MonoSol Rx, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D part 1, # 5 Exhibit D part 2, # 6 Exhibit E part 1, # 7 Exhibit E part 2, # 8 Civil Cover Sheet)(nmb) (Entered: 03/22/2016)

Entry #1 • 2016-03-21
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc